๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Planning patient education for cystic fibrosis: Application of a diagnostic framework

โœ Scribed by L. Kay Bartholomew; Dan K. Seilheimer; Guy S. Parcel; Susan H. Spinelli; Andres J. Pumariega


Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
990 KB
Volume
13
Category
Article
ISSN
0738-3991

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Clinical application of preimplantation
โœ V. Goossens; K. Sermon; W. Lissens; M. Vandervorst; A. Vanderfaeillie; M. De Rij ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 114 KB ๐Ÿ‘ 2 views

Cystic fibrosis (CF) is an autosomal recessive disease characterized by obstruction and chronic infections of the respiratory tract and pancreatic insufficiency. The gene was cloned in 1989 and the most frequent mutation was shown to be the delta F508 mutation. During PGD, embryos obtained in vitro

End-tidal estimates of arterial PCO2 for
โœ P. Pianosi; J. Hochman ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 671 KB

We set out to determine the effects of various estimates of arterial PCO2 (PaCO2) on calculation of cardiac output (Q) by the indirect Fick (CO2) method in healthy children and children with cystic fibrosis (CF), and to develop a prediction equation for children for PaCO2, based on end-tidal PCO2 (P

EMMA, a cost- and time-effective diagnos
โœ Virginie Caux-Moncoutier; Laurent Castรฉra; Carole Tirapo; Dorothรฉe Michaux; Mari ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 250 KB ๐Ÿ‘ 1 views

The detection of unknown mutations remains a serious challenge and, despite the expected benefits for the patient's health, a large number of genes are not screened on a routine basis. We present the diagnostic application of EMMA (Enhanced Mismatch Mutation Analysis(ยฎ) , Fluigent, Paris, France), a